143 related articles for article (PubMed ID: 2418010)
1. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
Modai I; Beigel Y; Cygielman G
J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010
[TBL] [Abstract][Full Text] [Related]
2. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
Petursson H; Bond PA; Smith B; Lader MH
Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
Beckmann H; Murphy DL
Neuropsychobiology; 1977; 3(1):49-55. PubMed ID: 895998
[TBL] [Abstract][Full Text] [Related]
4. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
[TBL] [Abstract][Full Text] [Related]
5. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R
Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
[TBL] [Abstract][Full Text] [Related]
6. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
Shekim WO; Javaid J; Davis JM; Bylund DB
Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
[TBL] [Abstract][Full Text] [Related]
8. Asthma and alcohol withdrawal as sources of artefact in urinary excretion of 3-methoxy-4-hydroxyl phenylglycol (MHPG).
Hollister LE; Prusmack JJ; Knopes K; Kanaske K
Commun Psychopharmacol; 1980; 4(2):135-40. PubMed ID: 7428334
[No Abstract] [Full Text] [Related]
9. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
[TBL] [Abstract][Full Text] [Related]
10. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
Linnoila M; Karoum F; Miller T; Potter WZ
Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
[TBL] [Abstract][Full Text] [Related]
11. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
Shekim WO; Javaid J; Dekirmenjian H; Chapel JL; Davis JM
Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
[TBL] [Abstract][Full Text] [Related]
12. Low level of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children having concomitantly high 3-methoxy-4-hydroxyphenyl glycol (MHPG) excretion.
Popa M; Stefănescu AM; Dumitriu L
Endocrinologie; 1989; 27(1):29-34. PubMed ID: 2474191
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
Maas JW; Koslow SH; Katz MM; Bowden CL; Gibbons RL; Stokes PE; Robins E; Davis JM
Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers.
Bieck PR; Firkusny L; Schick C; Antonin KH; Nilsson E; Schulz R; Schwenk M; Wollmann H
Clin Pharmacol Ther; 1989 Mar; 45(3):260-9. PubMed ID: 2920501
[TBL] [Abstract][Full Text] [Related]
15. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
[No Abstract] [Full Text] [Related]
16. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.
Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1261-71. PubMed ID: 7532316
[TBL] [Abstract][Full Text] [Related]
17. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
[TBL] [Abstract][Full Text] [Related]
18. Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children.
Brown GL; Ebert MH; Hunt RD; Rapoport JL
Biol Psychiatry; 1981 Aug; 16(8):779-87. PubMed ID: 7197170
[No Abstract] [Full Text] [Related]
19. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
Popa M; Stefănescu AM; Dumitriu L
Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome.
Bornstein RA; Baker GB
Int J Neurosci; 1988 Sep; 42(1-2):113-20. PubMed ID: 2463232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
